Abstract

The possibility of diagnostic and/or prognostic use of measuring the concentration of advanced oxidation protein products (AOPPs) in chronic diseases with well-documented involvement of oxidative stress (OS) in their pathogenesis were the subject of numerous studies. In the present study discussed the pathological conditions and disorders, in which the role of OS and oxidative damage of proteins is also indicated as one of the factors in their etiopathogenesis. The presented data concerned clinical and diagnostic aspects of AOPPs as well as biochemical mechanisms of disturbances in the infection and autoimmune diseases, cancers, genetic and neurological diseases. Participation of AOPPs in disturbances connected with fertility, pregnancy delivery and prematurity are also shown. Moreover the single literature data concerning other pathological states, in which AOPPs are also becoming the object of intensive investigations are presented. The review and application possibilities of AOPPs measurement as useful marker for diagnosis, prognosis and monitoring the course of these diseases were performed. Diagnostic or prognostic utility of AOPPs are especially indicated in the course of rheumatoid arthritis, development of pregnancy complication both in mother and child, and dementia. However, AOPPs measurement seems to be most promising in plasma or urine in course of cancer diseases.

References

• 1. Agarwal A., Gupta S., Sharma R.K.: Role of oxidative stress in femalereproduction. Reprod. Biol. Endocrinol., 2005; 3: 28
  Google Scholar
• 2. Agarwal A., Gupta S., Sikka S.: The role of free radicals and antioxidantsin reproduction. Curr. Opin. Obstet. Gynecol., 2006; 18: 325-332
  Google Scholar
• 3. Aksoy F., Yıldırım Y.S., Veyseller B., Demirhan H., Ozturan O.:Serum levels of advanced oxidation protein products in responseto allergen exposure in allergic rhinitis. Ear Nose Throat J., 2012;91: E32-E35
  Google Scholar
• 4. Alagozlu H., Gorgul A., Bilgihan A., Tuncer C., Unal S.: Increasedplasma levels of advanced oxidation protein products (AOPP) asa marker for oxidative stress in patients with active ulcerative colitis.Clin. Res. Hepatol. Gastroenterol., 2013; 37: 80-85
  Google Scholar
• 5. Alderman C.J., Shah S., Foreman J.C., Chain B.M., Katz D.R.: Therole of advanced oxidation protein products in regulation of dendriticcell function. Free Radic. Biol. Med., 2002; 32: 377-385
  Google Scholar
• 6. Avinash S.S., Anitha M., Vinodchandran, Rao G.M., Sudha K.,Shetty B.V.: Advanced oxidation protein products and total antioxidantactivity in colorectal carcinoma. Indian J. Physiol. Pharmacol.,2009; 53: 370-374
  Google Scholar
• 7. Barut O., Vural P., Sirin S., Aydin S., Dizdar Y.: The oxidant/antioxidantstatus and cell death mode in oral squamous cell carcinoma.Acta Odontol. Scand., 2012; 70: 303-308
  Google Scholar
• 8. Baskol G., Demir H., Baskol M., Kilic E., Ates F., Karakukcu C.,Ustdal M.: Investigation of protein oxidation and lipid peroxidationin patients with rheumatoid arthritis. Cell Biochem. Funct.,2006; 24: 307-311
  Google Scholar
• 9. Baskol G., Gumus K., Oner A., Arda H., Karakucuk S.: The role ofadvanced oxidation protein products and total thiols in diabeticretinopathy. Eur. J. Ophthalmol., 2008; 18: 792-798
  Google Scholar
• 10. Baskol G., Karakucuk S., Öner A., Mirza G.A., Kocer D.: SerumMDA and AOPP levels in age related macular degeneration. ErciyesTıp Dergisi, 2004; 26: 7-11
  Google Scholar
• 11. Baskol G., Korkmaz S., Erdem F., Caniklioglu A., Kocyigit M., AksuM.: Assessment of nitric oxide, advanced oxidation protein products,malondialdehyde, and thiol levels in patients with restless legs syndrome.Sleep Med., 2012; 13: 414-418
  Google Scholar
• 12. Baskol M., Baskol G., Kocer D., Ozbakir O., Yucesoy M.: Advancedoxidation protein products: a novel marker of oxidative stress in ulcerativecolitis. J. Clin. Gastroenterol., 2008; 42: 687-691
  Google Scholar
• 13. Bellieni C.V., Iantorno L., Perrone S., Rodriguez A., Longini M.,Capitani S., Buonocore G.: Even routine painful procedures can beharmful for the newborn. Pain, 2009; 147: 128-131
  Google Scholar
• 14. Belo L., Caslake M., Santos-Silva A., Castro E.M., Pereira-LeiteL., Quintanilha A., Rebelo I.: LDL size, total antioxidant status andoxidised LDL in normal human pregnancy: a longitudinal study.Atherosclerosis, 2004; 177: 391-399
  Google Scholar
• 15. Buonocore G., Perrone S., Longini M., Terzuoli L., Bracci R.: Totalhydroperoxide and advanced oxidation protein products in pretermhypoxic babies. Pediatr. Res., 2000; 47: 221-224
  Google Scholar
• 16. Buonocore G., Perrone S., Longini M., Vezzosi P., Marzocchi B.,Paffetti P., Bracci R.: Oxidative stress in preterm neonates at birthand on the seventh day of life. Pediatr. Res., 2002; 52: 46-49
  Google Scholar
• 17. Całkosiński I., Dobrzyński M., Całkosińska M., Seweryn E., Bronowicka-SzydełkoA., Dzierzba K., Ceremuga I., Gamian A.: Charakterystykaodczynu zapalnego. Postępy Hig. Med. Dośw., 2009;63: 395-408
  Google Scholar
• 18. Cardenas-Rodriguez N., Huerta-Gertrudis B., Rivera-EspinosaL., Montesinos-Correa H., Bandala C., Carmona-Aparicio L., Coballase-UrrutiaE.: Role of oxidative stress in refractory epilepsy: evidencein patients and experimental models. Int. J. Mol. Sci., 2013;14: 1455-1476
  Google Scholar
• 19. Cervellati C., Cremonini E., Bosi C., Magon S., Zurlo A., BergaminiC.M., Zuliani G.: Systemic oxidative stress in older patients withmild cognitive impairment or late onset Alzheimer’s disease. Curr.Alzheimer Res., 2013; 10: 365-372
  Google Scholar
• 20. Chandramathi S., Suresh K., Anita Z.B., Kuppusamy U.R.: Comparativeassessment of urinary oxidative indices in breast and colorectalcancer patients. J. Cancer Res. Clin. Oncol., 2009; 135: 319-323
  Google Scholar
• 21. Chandramathi S., Suresh K.G., Anita Z.B., Kuppusamy U.R.: Attenuationof hydrogen peroxide and ferric reducing/antioxidantpower serum levels in colorectal cancer patients with intestinalparasitic infection. Malays. J. Med. Sci., 2009; 16: 15-20
  Google Scholar
• 22. Chandramathi S., Suresh K., Anita Z.B., Kuppusamy U.R.: Elevatedlevels of urinary hydrogen peroxide, advanced oxidative proteinproduct (AOPP) and malondialdehyde in humans infected with intestinalparasites. Parasitology, 2009; 136: 359-363
  Google Scholar
• 23. Chang D., Sha Q., Zhang X., Liu P., Rong S., Han T., Liu P., Pan H.:The evaluation of the oxidative stress parameters in patients withprimary angle-closure glaucoma. PLoS One, 2011; 6: e27218
  Google Scholar
• 24. Chiu-Braga Y.Y., Hayashi S.Y., Schafranski M., Messias-ReasonI.J.: Further evidence of inflammation in chronic rheumatic valvedisease (CRVD): high levels of advanced oxidation protein products(AOPP) and high sensitive C-reactive protein (hs-CRP). Int. J. Cardiol.,2006; 109: 275-276
  Google Scholar
• 25. Da Silva A.S., Paim F.C., Santos R.C., Sangoi M.B., Moresco R.N.,Lopes S.T., Jaques J.A., Baldissarelli J., Morsch V.M., Monteiro S.G.:Nitric oxide level, protein oxidation and antioxidant enzymes in ratsinfected by Trypanosoma evansi. Exp. Parasitol., 2012; 132: 166-170
  Google Scholar
• 26. Demirbilek M.E., Kilic N., Komurcu H.F., Akin K.O.: Advancedoxidation protein products in aged with dementia. Am. J. Immunol.,2007; 3: 52-55
  Google Scholar
• 27. Dobryszycka W., Leszek J., Rymaszewska J.: Choroba Alzheimera- patogeneza, diagnostyka, leczenie. Wyd. Continuo, Wrocław2002, wyd. 1 28 Fialová L., Kalousová M., Soukupová J., Malbohan I., Krofta L.,Mikulíková L., Horejsová H., Stipek S., Zima T.: Levels of advancedoxidation protein products (AOPP) in the first trimester of pregnancy.Sb. Lek., 2003; 104: 95-102
  Google Scholar
• 28. – December 1 (Abstracts)
  Google Scholar
• 29. Fialová L., Malbohan I., Kalousová M., Soukupová J., Krofta L.,Stipek S., Zima T.: Oxidative stress and inflammation in pregnancy.Scand. J. Clin. Lab. Invest., 2006; 66: 121-127
  Google Scholar
• 30. Fulgenzi A., Wasserman K., Corsi M.M.: Significance of autoantibodiesto oxidatively modified LDL in plasma of children with Downsyndrome. Clin. Chem., 2001; 47: 1135-1137
  Google Scholar
• 31. Gangemi S., Allegra A., Aguennouz M., Alonci A., Speciale A.,Cannavo A., Cristani M., Russo S., Spatari G., Alibrandi A., MusolinoC.: Relationship between advanced oxidation protein products, advancedglycation end products, and S-nitrosylated proteins withbiological risk and MDR-1 polymorphisms in patients affected byB-chronic lymphocytic leukemia. Cancer Invest., 2012; 30: 20-26
  Google Scholar
• 32. Gangemi S., Allegra A., Alonci A., Cristani M., Russo S., SpecialeA., Penna G., Spatari G., Cannavò A., Bellomo G., Musolino C.: Increaseof novel biomarkers for oxidative stress in patients with plasma celldisorders and in multiple myeloma patients with bone lesions. Inflamm.Res., 2012; 61: 1063-1067
  Google Scholar
• 33. Garcia-Fernandez M.I., Gheduzzi D., Boraldi F., Paolinelli C.D.,Sanchez P., Valdivielso P., Morilla M.J., Quaglino D., Guerra D., CasolariS., Bercovitch L., Pasquali-Ronchetti I.: Parameters of oxidativestress are present in the circulation of PXE patients. Biochim. Biophys.Acta, 2008; 1782: 474-481
  Google Scholar
• 34. Gelisgen R., Genc H., Kayali R., Oncul M., Benian A., Guralp O., UludagS., Cakatay U., Albayrak M., Uzun H.: Protein oxidation markers in womenwith and without gestational diabetes mellitus: a possible relationwith paraoxonase activity. Diabetes Res. Clin. Pract., 2011; 94: 404-409
  Google Scholar
• 35. Goi G., Baquero-Herrera C., Licastro F., Dogliotti G., Corsi M.M.:Advanced oxidation protein products (AOPP) and high-sensitiveC-reactive protein (hs-CRP) in an ‘‘atheroma-free model’’: Down’ssyndrome. Int. J. Cardiol., 2006; 113: 427-429
  Google Scholar
• 36. Grosso S., Longini M., Rodriguez A., Proietti F., Piccini B., BalestriP., Buonocore G.: Oxidative stress in children affected by epilepticencephalopathies. J. Neurol. Sci., 2011; 300: 103-106
  Google Scholar
• 37. Guilpain P., Chéreau C., Goulvestre C., Servettaz A., Montani D.,Tamas N., Pagnoux C., Hachulla E., Weill B., Guillevin L., MouthonL., Batteux F.: The oxidation induced by antimyeloperoxidase antibodiestriggers fibrosis in microscopic polyangiitis. Eur. Respir. J.,2011; 37: 1503-1513 38 Gutowicz M.: Wpływ reaktywnych form tlenu na ośrodkowyukład nerwowy. Postępy Hig. Med. Dośw., 2011; 65: 104-113
  Google Scholar
• 38. (Suppl.): 140-149
  Google Scholar
• 39. Hamouda H.E., Zakaria S.S, Ismail S.A., Khedr M.A., Mayah W.W.:p53 antibodies, metallothioneins, and oxidative stress markers inchronic ulcerative colitis with dysplasia. World J. Gastroenterol.,2011; 17: 2417-2423
  Google Scholar
• 40. Hartmann S.E., Pialoux V., Leigh R., Poulin M.J.: Decreased cerebrovascularresponse to CO2 in post-menopausal females with COPD:role of oxidative stress. Eur. Respir. J., 2012; 40: 1354-1361
  Google Scholar
• 41. Herrera E.: Lipid metabolism in pregnancy and its consequencesin the fetus and newborn. Endocrine, 2002; 19: 43-55
  Google Scholar
• 42. Ignyś I., Krauss H., Malewski W., Sosnowski P., Krawczyński M.:Wpływ leczenia 5ASA na wykładniki stresu oksydacyjnego u dzieciz nieswoistymi zapaleniami jelita grubego. Nowa Pediatria, 2003;7: 99-103
  Google Scholar
• 43. Kalousová M., Fialová L., Zima T., Malbohan I.M., Krofta L., SoukupováJ., Mikulíková L., Stipek S.: Advanced oxidation proteinproducts in pregnancy. Ceska Gynekol., 2002; 67: 194-197
  Google Scholar
• 44. Kalousová M., Zák A., Soukupová J., Stipek S., Malbohan I.M.,Zima T.: Advanced glycation and oxidation products in patients withatherosclerosis. Cas. Lek. Cesk., 2005; 144: 385-389
  Google Scholar
• 45. Kalousová M., Zima T., Tesar V., Dusilová-Sulková S., Skrha J.:Advanced glycoxidation end products in chronic diseases – clinicalchemistry and genetic background. Mutat. Res., 2005; 579: 37-46
  Google Scholar
• 46. Kamanli A., Naziroglu M., Aydilek N., Hecievliyagil C.: Plasmalipid peroxidation and antioxidant levels In patients with rheumatoidarthritis. Cell Biochem. Funct., 2004; 22: 53-57
  Google Scholar
• 47. Kaneda H., Taguchi J., Ogasawara K., Aizawa T., Ohno M.: Increasedlevel of advanced oxidation protein products in patientswith coronary artery disease. Atherosclerosis, 2002; 162: 221-225
  Google Scholar
• 48. Karpel E.: Mediatory ogólnoustrojowej odpowiedzi zapalnej –znaczenie w praktyce klinicznej intensywnej terapii. AnestezjologiaIntensywna Terapia, 2001; 3: 181-190
  Google Scholar
• 49. Keskin N., Civilibal M., Elevli M., Koldas M., Duru N.S., Ozturk H.:Elevated plasma advanced oxidation protein products in children withHenoch-Schonlein purpura. Pediatr. Nephrol., 2011; 26: 1989-1993
  Google Scholar
• 50. Komosinska-Vassev K., Olczyk P., Winsz-Szczotka K., KuznikTrochaK., Klimek K., Olczyk K.: Age- and gender-related alterationin plasma advanced oxidation protein products (AOPP) and glycosaminoglycan(GAG) concentrations in physiological ageing. Clin.Chem. Lab. Med., 2012; 50: 557-563
  Google Scholar
• 51. Kosova F., Cetin B., Akinci M., Aslan S., Ari Z., Sepici A., Altan N.,Cetin A.: Advanced oxidation protein products, ferrous oxidation inxylenol orange, and malondialdehyde levels in thyroid cancer. Ann.Surg. Oncol., 2007; 14: 2616-2620
  Google Scholar
• 52. Kratz E., Ferens-Sieczkowska M., Zimmer M., Piwowar A.: Oxidativeprotein damage and oxidative stress markers in the seminalplasma of subfertile men. J. Reproduktionsmed. Endokrinol., 2012;9: 386-387. 7th European Congress of Andrology (ECA). Berlin, November
  Google Scholar
• 53. Król K., Konopka T.: Reaktywne pochodne tlenu i mechanizmyantyoksydacyjne w patogenezie zapaleń przyzębia. Dent. Med. Probl.,2003; 40: 121-128
  Google Scholar
• 54. Krzystek-Korpacka M., Neubauer K., Berdowska I., Boehm D.,Zielinski B., Petryszyn P., Terlecki G., Paradowski L., Gamian A.: Enhancedformation of advanced oxidation protein products in IBD.Inflamm. Bowel Dis., 2008; 14: 794-802
  Google Scholar
• 55. Kucharzik T., Walsh S.V., Chen J., Parkos C.A., Nusrat A.: Neutrophiltransmigration in inflammatory bowel disease is associated withdifferential expression of epithelial intercellular junction proteins.Am. J. Pathol., 2001; 159: 2001-2009
  Google Scholar
• 56. Li Q., Brodsky J.L., Conlin L.K., Pawel B., Glatz A.C., Gafni R.I.,Schurgers L., Uitto J., Hakonarson H., Deardorff M.A., Levine M.A.:Mutations in the ABCC6 gene as a cause of generalized arterial calcificationof infancy: genotypic overlap with pseudoxanthoma elasticum.J. Invest. Dermatol., 2014; 134: 658-665
  Google Scholar
• 57. Li Q., Jiang Q., Uitto J.: Pseudoxanthoma elasticum: oxidativestress and antioxidant diet in a mouse model (Abcc6-/-). J. Invest.Dermatol., 2008; 128: 1160-1164
  Google Scholar
• 58. Licastro F., Dogliotti G., Goi G., Malavazos A.E., Chiappelli M.,Corsi M.M.: Oxidated low-density lipoproteins (oxLDL) and peroxidesin plasma of Down syndrome patients. Arch. Gerontol. Geriatr.,2007; 44 (Suppl. 1): 225-232
  Google Scholar
• 59. Liu H., Han T., Tian J., Zhu Z.Y., Liu Y., Li Y., Xiao S.X., Li Y., FengY.Y.: Monitoring oxidative stress in acute-on-chronic liver failure byadvanced oxidation protein products. Hepatol. Res., 2012; 42: 171-180
  Google Scholar
• 60. Llurba E., Gratacós E., Martín-Gallán P., Cabero L., DominguezC.: A comprehensive study of oxidative stress and antioxidant statusin preeclampsia and normal pregnancy. Free Radic. Biol. Med.,2004; 37: 557-570
  Google Scholar
• 61. López J., González M.E., Lorigados L., Morales L., Riverón G.,Bauzá J.Y.: Oxidative stress markers in surgically treated patientswith refractory epilepsy. Clin. Biochem., 2007; 40: 292-298
  Google Scholar
• 62. Lozovoy M.A., Simao A.N., Panis C., Rotter M.A., Reiche E.M.,Morimoto H.K., Lavado E., Cecchini R., Dichi I.: Oxidative stress isassociated with liver damage, inflammatory status, and corticosteroidtherapy in patients with systemic lupus erythematosus. Lupus,2011; 20: 1250-1259
  Google Scholar
• 63. Makker K., Agarwal A., Sharma R.: Oxidative stress and maleinfertility. Indian J. Med. Res., 2009; 129: 357-367
  Google Scholar
• 64. Mancuso M., Bonanni E., LoGerfo A., Orsucci D., Maestri M.,Chico L., DiCoscio E., Fabbrini M., Siciliano G., Murri L.: Oxidativestress biomarkers in patients with untreated obstructive sleep apneasyndrome. Sleep Med., 2012; 13: 632-636
  Google Scholar
• 65. Manczak M., Anekonda T.S., Henson E., Park B.S., Quinn J., ReddyP.H.: Mitochondria are a direct site of Aβ accumulation in Alzheimer’sdisease neurons: implications for free radical generation andoxidative damage in disease progression. Hum. Mol. Genet., 2006;15: 1437-1449
  Google Scholar
• 66. Matyska-Piekarska E., Łuszczewski A., Łącki J., Wawer I.: Rolastresu oksydacyjnego w etiopatogenezie reumatoidalnego zapaleniastawów. Postępy Hig. Med. Dośw., 2006; 60: 617-623
  Google Scholar
• 67. Meldrum B.S.: Glutamate as neurotransmitter in the brain: reviewof physiology and pathology. J. Nutr., 2000; 130 (Suppl. 4S):1007S-1015S
  Google Scholar
• 68. Murdoch J.C., Rodger J.C., Rao S.S., Fletcher C.D., Dunnigan M.G.:Down’s syndrome: an atheroma-free model? Br. Med. J., 1977; 2: 226-228
  Google Scholar
• 69. Nayyar A.S., Khan M.: In search of malignant transformation:a pilot study. J. Cancer Res. Ther., 2012; 8: 277-281
  Google Scholar
• 70. Norheim K.B., Jonsson G., Harboe E., Hanasand M., Gøransson L., OmdalR.: Oxidative stress, as measured by protein oxidation, is increased inprimary Sjogren’s syndrome. Free Radic. Res., 2012; 46: 141-146
  Google Scholar
• 71. Noyan T., Guducuoglu H., Ilhan M.: A study of oxidative stressparameters in anti-Helicobacter pylorus immunoglobulin G positiveand negative gastric cancer patients. Yonsei Med. J., 2009; 50: 677-682
  Google Scholar
• 72. Noyan T., Güler A., Sekeroglu M.R., Kamaci M.: Serum advanced oxidationprotein products, myeloperoxidase and ascorbic acid in pre-eclampsiaand eclampsia. Aust. N. Z. J. Obstet. Gynaecol., 2006; 46: 486-491
  Google Scholar
• 73. Onder M., Gürer M.A.: The multiple faces of Behcet’s disease and itsaetiological factors. J. Eur. Acad. Dermatol. Venereol., 2001; 15: 126-136
  Google Scholar
• 74. Orrell R.W.: Amyotrophic lateral sclerosis:copper/zinc superoxidedismutase (SOD1) gene mutations. Neuromuscul. Disord., 2000; 10: 63-68
  Google Scholar
• 75. Pagano G., Castello G.: Oxidative stress and mitochondrial dysfunctionin Down syndrome. Adv. Exp. Med. Biol., 2012; 724: 291-299
  Google Scholar
• 76. Pasquali-Ronchetti I., Garcia-Fernandez M.I., Boraldi F., QuaglinoD., Gheduzzi D., De Vincenzi Paolinelli C., Tiozzo R., BergaminiS., Ceccarelli D., Muscatello U.: Oxidative stress in fibroblasts frompatients with pseudoxanthoma elasticum: possible role in the pathogenesisof clinical manifestations. J. Pathol., 2006; 208: 54-61
  Google Scholar
• 77. Perrone S., Mussap M., Longini M., Fanos V., Bellieni C.V., ProiettiF., Cataldi L., Buonocore G.: Oxidative kidney damage in pretermnewborns during perinatal period. Clin. Biochem., 2007; 40: 656-660
  Google Scholar
• 78. Perrone S., Tataranno M.L., Negro S., Cornacchione S., LonginiM., Proietti F., Soubasi V., Benders M.J., Van Bel F., Buonocore G.: Mayoxidative stress biomarkers in cord blood predict the occurrence ofnecrotizing enterocolitis in preterm infants? J. Matern. Fetal NeonatalMed., 2012; 25 (Suppl. 1): 128-131
  Google Scholar
• 79. Perrone S., Tataranno M.L., Negro S., Longini M., Marzocchi B.,Proietti F., Iacoponi F., Capitani S., Buonocore G.: Early identificationof the risk for free radical-related diseases in preterm newborns.Early Hum. Dev., 2010; 86: 241-244
  Google Scholar
• 80. Pialoux V., Mounier R., Brown A.D., Steinback C.D., RawlingJ.M., Poulin M.J.: Relationship between oxidative stress and HIF-1αmRNA during sustained hypoxia in humans. Free Radic. Biol. Med.,2009; 46: 321-326
  Google Scholar
• 81. Piwowar A.: Aspekty biochemiczne i kliniczne zaawansowanychproduktów utleniania białek w chorobach nerek i zaburzeniach metabolicznych.Postępy Hig. Med. Dośw., 2014; 68: 179-190
  Google Scholar
• 82. Piwowar A., Knapik-Kordecka M., Warwas M.: Comparison ofthe usefulness of plasma levels of oxidatively modified forms of albuminin estimating kidney dysfunction in diabetic patients. Clin.Invest. Med., 2010; 33: E109
  Google Scholar
• 83. Riverón G., Cuétara E., Hernández E.W., Bécquer P., Acosta T.,Marin L., Pereira N., Gutiérrz R., Pupo J., Martinez O., Pandolfi A.,Cuevillas G., Llibre J.J.: Oxidative markers and antioxidant defencesin patients diagnosed with probable Alzheimer disease. Pharmacologyonline,2007; 1: 20-24
  Google Scholar
• 84. Roberts J.M., Hubel C.A.: Oxidative stress in preeclampsia. Am.J. Obstet. Gynecol., 2004; 190: 1177-1178
  Google Scholar
• 85. Rysavá R., Kalousová M., Zima T., Dostál C., Merta M., Tesar V.:Does renal function influence plasma levels of advanced glycationand oxidation protein products in patients with chronic rheumaticdiseases complicated by secondary amyloidosis? Kidney Blood Press.Res., 2007; 30: 1-7
  Google Scholar
• 86. Safarpour A.R., Hosseini S.V., Mehrabani D.: Epidemiology of inflammatorybowel diseases in Iran and Asia. Iran. J. Med. Sci., 2013;
  Google Scholar
• 87. Sandal G., Uras N., Gokmen T., Oguz S.S., Erdeve O., Dilmen U.:Assessment of oxidant/antioxidant system in newborns and theirbreast milks. J. Matern. Fetal Neonatal Med., 2013; 26: 540-543
  Google Scholar
• 88. Siciliano G., Piazza S., Carlesi C., Del Corona A., Franzini M., PompellaA., Malvaldi G., Mancuso M., Paolicchi A., Murri L.: Antioxidantcapacity and protein oxidation in cerebrospinal fluid of amyotrophiclateral sclerosis. J. Neurol., 2007; 254: 575-580
  Google Scholar
• 89. Slowik A., Tomik B., Wolkow P.P., Partyka D., Turaj W., MaleckiM.T., Pera J., Dziedzic T., Szczudlik A., Figlewicz D.A.: Paraoxonasegene polymorphisms and sporadic ALS. Neurology, 2006; 67: 766-770
  Google Scholar
• 90. Song Y.L., Quan S., Tian J.W., Li H., Chen S.M., Xing F.Q.: Relationshipbetween protein oxidation levels in the follicular fluid and theoutcome parameters of in vitro fertilization-embryo transplantation.Nan Fang Yi Ke Da Xue Xue Bao, 2009; 29: 160-163
  Google Scholar
• 91. Stanojkovic I., Kotur-Stevuljevic J., Milenkovic B., Spasic S., VujicT., Stefanovic A., Llic A., Ivanisevic J.: Pulmonary function, oxidativestress and inflammatory markers in severe COPD exacerbation.Respir. Med., 2011; 105 (Suppl. 1): S31-S37
  Google Scholar
• 92. Ścibior-Bentkowska D., Czeczot H.: Komórki nowotworowea stres oksydacyjny. Postępy Hig. Med. Dośw., 2009; 63: 58-72
  Google Scholar
• 93. Tanaka M., Tokunaga K., Maruyama T., Otagiri M., TominagaY., Itoh K., Matsushita K., Komaba H., Fukagawa M.: Parathyroidectomymarkedly reduces oxidative stress in a patient with primaryhyperparathyroidism. Ther. Apher. Dial., 2011; 15 (Suppl. 1): 38-41
  Google Scholar
• 94. Tesarová P., Kalousová M., Trnková B., Soukupová J., ArgalásováS., Mestek O., Petruzelka L., Zima T.: Carbonyl and oxidative stress inpatients with breast cancer – is there a relation to the stage of thedisease? Neoplasma, 2007; 54: 219-224
  Google Scholar
• 95. Tesarová P., Kvasnicka J., Umlaufová A., Homolková J., KalousováM., Tesar V.: Soluble adhesion molecules in female patients withbreast carcinoma. Cas. Lek. Cesk., 2003; 142: 292-299
  Google Scholar
• 96. Toescu V., Nuttall S.L., Martin U., Kendall M.J., Dunne F.: Oxidativestress and normal pregnancy. Clin. Endocrinol., 2002; 57: 609-613
  Google Scholar
• 97. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., TelserJ.: Free radicals and antioxidants in normal physiological functionsand human disease. Int. J. Biochem. Cell Biol., 2007; 39: 44-84
  Google Scholar
• 98. Varga P., Oláh A.V., Oláh E.: Biochemical alterations in patientswith Down syndrome. Orv. Hetil., 2008; 149: 1203-1213
  Google Scholar
• 99. Veyseller B., Aksoy E., Ertas B., Keskin M., Ozturan O., YildirimY.S., Bayraktar E.G., Oztürk H.: A new oxidative stress marker in patientswith nasal polyposis: advanced oxidation protein products(AOPP). B-ENT, 2010; 6: 105-109
  Google Scholar
• 100. Witko-Sarsat V., Friedlander M., Capeillère-Blandin C., NguyenKhoaT., Nguyen A.T., Zingraff J., Jungers P., Descamps-Latscha B.:Advanced oxidation protein products as a novel marker of oxidativestress in uremia. Kidney Int., 1996; 49: 1304-1313
  Google Scholar
• 101. Xian L.W., Li T.P., Wei Y.E., Wu S.P., Ma L.: Relation of advancedoxidation protein products with VEGF and TGF-β1 in colon cancercells exposed to intermittent hypoxia. Nan Fang Yi Ke Da Xue XueBao, 2011; 31: 619-623
  Google Scholar
• 102. Xiong Y., Tang H., Li X., Liang Y.B., Liao X.X., Zhan H., Jing X.L., LiY.J., Ma Z.F.: The expression and clinical implication of advanced oxidizedprotein products in patients with multiple organ dysfunctionsyndrome. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 2008; 20: 542-545
  Google Scholar
• 103. Yazici C., Köse K., Calis M., Demir M., Kirnap M., Ates F.: Increasedadvanced oxidation protein products in Behcet’s disease:a new activity marker? Br. J. Dermatol., 2004; 151: 105-111
  Google Scholar
• 104. Yazici C., Köse K., Calis M., Kuzugüden S., Kirnap M.: Proteinoxidation status in patients with ankylosing spondylitis. Rheumatology,2004; 43: 1235-1239
  Google Scholar
• 105. Yildirim Z., Yildirim F., Ucgun N.I., Kilic N.: The evaluation ofthe oxidative stress parameters in nondiabetic and diabetic senilecataract patients. Biol. Trace Elem. Res., 2009; 128: 135-143
  Google Scholar
• 106. Zamłyński J., Olejek A., Więcek A., Mańka G., Chudek J., BodzekP., Damasiewicz-Bodzek A.: Wpływ zmian metabolicznych w ciążyprawidłowej i powikłanej cukrzycą na wewnątrzmaciczne wzrastaniepłodu. Postępy Hig. Med. Dośw., 2005; 59: 490-495
  Google Scholar
• 107. Zhong Z.M., Bai L., Chen J.T.: Advanced oxidation protein productsinhibit proliferation and differentiation of rat osteoblast-likecells via NF-κB pathway. Cell. Physiol. Biochem., 2009; 24: 105-114
  Google Scholar
• 108. Zuwała-Jagiełło J., Pazgan-Simon M., Simon K., Warwas M.:Advanced oxidation protein products and inflammatory markersin liver cirrhosis: a comparison between alcohol-related and HCVrelatedcirrhosis. Acta Biochim. Pol., 2011; 58: 59-65
  Google Scholar

Full text